← Leaderboards
Kevin D Mills
Jackson Laboratory
$6,985,473
Attributed
$6,985,473
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2006–17$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$6,985,473 · 12
By mechanism
R01$2,589,397 · 2
R42$1,999,998 · 1
P20$1,451,115 · 6
R25$731,497 · 2
R41$213,466 · 1
Top collaborators
No co-investigators on record.
Most similar at Jackson Laboratory
Same institution · by research overlap
- Carol J Bult$70,917,571
- Rosemarie E Seymour$475,702
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGenomic InstabilityPathway InteractionsDna Double Strand BreakTumorOncogenicLymphoidGenesB-LymphocytesDouble Strand Break RepairRepairedAnimal ModelBaseCellsMouse ModelGeneticDesignLymphomaChromosomal InstabilityMolecularInstitutionProtein P53Research PersonnelTumorigenesis
Grant awards (23)
Developing Therapeutics That Target RAD51 To Treat Leukemia and Lymphoma$961,015
R42 · FY2017 · CA · contact PI
Developing Therapeutics That Target RAD51 To Treat Leukemia and Lymphoma$1,038,983
R42 · FY2016 · CA · contact PI
Short Course on Experimental Models of Human Cancer$147,557
R25 · FY2015 · CA · contact PI
Workshop on Techniques in Modeling Human Cancer in Mice$72,606
R25 · FY2015 · CA · contact PI
Developing Therapeutics That Target RAD51 to Treat Leukemia and Lymphoma$213,466
R41 · FY2014 · CA · contact PI
Short Course on Experimental Models of Human Cancer$147,557
R25 · FY2014 · CA · contact PI
Workshop on Techniques in Modeling Human Cancer in Mice$72,606
R25 · FY2014 · CA · contact PI
Short Course on Experimental Models of Human Cancer$147,557
R25 · FY2013 · CA · contact PI
Homologous Recombination in Genome Stability and Tumor Suppression$350,219
R01 · FY2012 · CA · contact PI
Short Course on Experimental Models of Human Cancer$143,614
R25 · FY2012 · CA · contact PI
Homologous Recombination in Genome Stability and Tumor Suppression$350,219
R01 · FY2011 · CA · contact PI
4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT$150,866
P20 · FY2011 · RR · contact PI
Homologous Recombination in Genome Stability and Tumor Suppression$361,050
R01 · FY2010 · CA · contact PI
4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT$250,424
P20 · FY2010 · RR · contact PI
Homologous Recombination in Genome Stability and Tumor Suppression$361,050
R01 · FY2009 · CA · contact PI
Molecular Mechanisms of Lymphomagenesis$289,553
R01 · FY2009 · CA · contact PI
4:LYMPHOMA SUPPRESSION:DNA BREAK REPAIR IN STEM CELLS AND THEIR MICROENVIRONMENT$243,975
P20 · FY2009 · RR · contact PI
Molecular Mechanisms of Lymphomagenesis$289,553
R01 · FY2008 · CA · contact PI
PROJECT 9: STEM CELL FUNCTION & GENOME INSTABILITY IN LYMPHOMYELOID NEOPLASIA$288,973
P20 · FY2008 · RR · contact PI
PROJECT 9: STEM CELL FUNCTION & GENOME INSTABILITY IN LYMPHOMYELOID NEOPLASIA$390,677
P20 · FY2007 · RR · contact PI
Molecular Mechanisms of Lymphomagenesis$289,553
R01 · FY2007 · CA · contact PI
Molecular Mechanisms of Lymphomagenesis$298,200
R01 · FY2006 · CA · contact PI
PROJECT 9: STEM CELL FUNCTION & GENOME INSTABILITY IN LYMPHOMYELOID NEOPLASIA$126,200
P20 · FY2006 · RR · contact PI